Office of National Drug Control Policy bannerskip
skip tertiary linksHome | About | Site Map | Contact

Home | About | Staff Bios | A. Thomas McLellan, Ph.D.

Staff Bios

A. Thomas McLellan, Ph.D.
Deputy Director
White House Office of National Drug Control Policy

On August 10, 2009, A. Thomas McLellan, Ph.D. was sworn in as the Deputy Director of the Office of National Drug Control Policy. As Deputy Director, Dr. McLellan serves as the primary advisor to the Director on a broad range of drug control issues and assists in the formulation and implementation of the President's National Drug Control Strategy.

Dr. McLellan brings 35 years of addiction treatment research to the position, most recently at the Treatment Research Institute, a non-profit organization that he co-founded in 1992 to transform the way science is used to understand substance abuse. Dr. McLellan's contributions to the advancement of substance abuse research and the application of these findings to treatment systems and public policy have changed the landscape of addiction science and improved the lives of countless Americans and their families.

In his career he has published over 400 articles and chapters on addiction research. From 2000-2009 he was editor-in-chief of the Journal of Substance Abuse Treatment, and he has also served on several other editorial boards of scientific journals.

Dr. McLellan is the recipient of several distinguished awards including the Life Achievement Awards of the American and British Societies of Addiction Medicine (2001 & 2003); the Robert Wood Johnson Foundation Innovator Award (2005); and awards for Distinguished Contribution to Addiction Medicine from the Swedish (2002) and Italian (2002) Medical Associations.

Dr. McLellan holds a B.A. from Colgate University and his M.S. and Ph.D. from Bryn Mawr College. He received postgraduate training in psychology at Oxford University in England.

Blog News

More Blog News

FAIR Act

Pursuant to the Federal Activities Inventory Reform (FAIR) Act, be advised that the Office of National Drug Control Policy (ONDCP) does not perform any commercial activities by in-house employees. more

Information Quality Guidelines

The Office of National Drug Control Policy publishes these guidelines in accordance with the Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information Disseminated by Federal Agencies (Government-wide guidelines) published in interim final form by OMB in the Federal Register in Volume 66, No. 189 at 49718 on Friday, September 28, 2001, and in final form in Volume 2, No. 67 at 8452 on February 22, 2002.

Guide to Unsolicited Proposals

ONDCP strongly encourages potential offerors to participate in the preliminary process before expending time or money preparing an Unsolicited Proposal.

Ethics Policies

Public Financial Disclosure (SF278) Process
Process For Confidential Financial Disclosure Report Filers

The Anti-Drug logo

Above The Influence logo

MethResources.gov

skip navigationInformation Quality Guidelines | Privacy Policy | Site Map | Disclaimer | Accessibility | FOIA